Cabot Corp to Acquire Full Control of Norchem JV
Ticker: CBT · Form: 8-K · Filed: Jul 12, 2024 · CIK: 16040
Sentiment: neutral
Topics: acquisition, joint-venture
Related Tickers: CBT
TL;DR
Cabot buying out its partner in Norchem JV, full ownership incoming.
AI Summary
Cabot Corporation announced on July 12, 2024, that it has entered into a definitive agreement to acquire the remaining 50% interest in its joint venture, Norchem, from its partner, Norquay. This transaction is expected to close in the third quarter of fiscal year 2024. Cabot Corporation will acquire the stake for an undisclosed amount, which will be funded through existing cash resources.
Why It Matters
This acquisition will give Cabot Corporation full ownership and control over Norchem, potentially leading to greater strategic flexibility and integration of operations.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a business transaction with no immediate negative financial implications mentioned.
Key Players & Entities
- Cabot Corporation (company) — Registrant
- Norchem (company) — Joint Venture
- Norquay (company) — Joint Venture Partner
- July 12, 2024 (date) — Report Date
- third quarter of fiscal year 2024 (date) — Expected Closing Period
FAQ
What is the specific dollar amount Cabot Corporation is paying for the remaining 50% of Norchem?
The filing does not disclose the specific dollar amount for the acquisition of the remaining 50% interest in Norchem.
When is the acquisition of Norchem expected to be completed?
The acquisition is expected to close in the third quarter of fiscal year 2024.
How will Cabot Corporation fund this acquisition?
The acquisition will be funded through existing cash resources.
What is Cabot Corporation's current ownership stake in Norchem before this acquisition?
Cabot Corporation currently holds a 50% interest in its joint venture, Norchem.
Who is Cabot Corporation's partner in the Norchem joint venture?
Cabot Corporation's partner in the Norchem joint venture is Norquay.
Filing Stats: 643 words · 3 min read · ~2 pages · Grade level 11.7 · Accepted 2024-07-12 16:20:31
Key Financial Figures
- $1 — nge on which registered Common Stock, $1 par value per share CBT The New Yor
- $1.00 — shares of Cabot common stock, par value $1.00 per share, having a value as close as p
- $77,500 — having a value as close as possible to $77,500 on such date, which amount was calculat
- $155,000 — ock grant for non-employee directors of $155,000. Item7.01 Regulation FD Disclosure.
Filing Documents
- d566319d8k.htm (8-K) — 27KB
- d566319dex991.htm (EX-99.1) — 9KB
- 0001193125-24-178596.txt ( ) — 160KB
- cbt-20240712.xsd (EX-101.SCH) — 3KB
- cbt-20240712_lab.xml (EX-101.LAB) — 18KB
- cbt-20240712_pre.xml (EX-101.PRE) — 11KB
- d566319d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release issued by Cabot Corporation on July 12, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CABOT CORPORATION By: /s/ Sean D. Keohane Name: Sean D. Keohane Title: President and Chief Executive Officer Date: July 12, 2024